A detailed history of Mcia Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcia Inc holds 254 shares of LLY stock, worth $197,769. This represents 0.05% of its overall portfolio holdings.

Number of Shares
254
Previous 238 6.72%
Holding current value
$197,769
Previous $215,000 4.65%
% of portfolio
0.05%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $12,354 - $15,360
16 Added 6.72%
254 $225,000
Q2 2024

Jul 16, 2024

BUY
$724.87 - $909.04 $172,519 - $216,351
238 New
238 $215,000
Q4 2020

Jan 12, 2021

BUY
$130.46 - $172.63 $194,776 - $257,736
1,493 New
1,493 $252,000
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $65,470 - $70,224
-799 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
799
799 $66,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mcia Inc Portfolio

Follow Mcia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcia Inc with notifications on news.